Application of SPRA Technology for Delivery of Erythropoietin: Stability Evaluation of Conjugated Erythropoietin with Adamantane and in SPRA Inclusion Complex

BACKGROUND: As a widely used therapeutic protein, recombinant human erythropoietin (rhEPO) is currently one of the most effective biopharmaceuticals on the market for the treatment of anemia in patients with chronic renal disease. Increasing in vivo rhEPO half-life and its bioactivity is a significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Bahareh, Zarghi, Afshin, Mahboubi, Arash, Aboofazeli, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brieflands 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990512/
https://www.ncbi.nlm.nih.gov/pubmed/36896318
http://dx.doi.org/10.5812/ijpr-134282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990512/
https://www.ncbi.nlm.nih.gov/pubmed/36896318
http://dx.doi.org/10.5812/ijpr-134282

Ejemplares similares